Ribosomal proteins have emerged as novel regulators of the Mdm2-p53 feedback loop, especially in the context of ribosomal stress. RPS26 is a recently identified Diamond-Blackfan Anemia-related ribosomal protein and its role in p53 activation has not been previously explored. In this study we found knockdown of RPS26 induced p53 stabilization and activation via a RPL11-dependent mechanism, resulting in p53-dependent cell growth inhibition. Moreover, RPS26 has the ability to interact with Mdm2 and inhibits Mdm2-mediated p53 ubiquitination that leads to p53 stabilization upon overexpression. Importantly, we discovered that RPS26 knockdown impaired p53's ability to transcriptionally activate its target genes in response to DNA damage, without affecting its stability. Accordingly, the cells lost the ability to induce G2/M cell cycle arrest. We further found that upon RPS26 knockdown, the DNA damage induced recruitment of p53 to the promoters of its target genes and p53 acetylation were both greatly reduced. In addition, RPS26 can interact with p53 independent of Mdm2 and coexist in a complex with p53 and p300. These data establish a role of RPS26 in DNA damage response by directly influencing p53 transcriptional activity, and suggest that RPS26 acts distinctively in different scenarios of p53 activation. Our finding also implicates p53 transcriptional activity control as an important mechanism of p53 regulation by ribosomal proteins.
INTRODUCTION
p53 is a sequence-specific transcription factor. Its mutation and inactivation is associated with the majority of tumors, making it one of the most important tumor suppressors.
1,2 p53 suppresses tumor formation by transcriptionally upregulating its target genes involved in cell cycle arrest, apoptosis and cellular senescence in response to a variety of stress stimulations. [2] [3] [4] Therefore, proper activation of p53 is critical for normal cell functions.
p53 activation mainly involves protein upregulation and modifications. In normal and unstressed cells, the protein level of p53 is extremely low due to the ubiquitin ligase Mdm2-induced ubiquitination and degradation. 5, 6 In stressed conditions, this inhibitory effect of Mdm2 is disrupted, leading to rapid accumulation of p53. For instance, upon DNA damage p53 and Mdm2 are quickly phosphorylated, resulting in separation of p53 and Mdm2, whereby p53 is stabilized and upregulated. [7] [8] [9] [10] Accompanying its stabilization, p53 is also subject to various modifications. Some modifications, such as phosphorylation on the N-terminal region of p53, contribute to p53 protein stabilization, whereas others, notably acetylation, enhance its transcription activity. [11] [12] [13] Ribosomal proteins have recently emerged as important factors in p53 activation in response to ribosomal stress, also called nucleolar stress. 14, 15 Ribosomal stress induces p53 activation and checkpoint control to ensure the integrity and functionality of ribosomes. Ribosomal stress is generated when the normal flow of ribosomal production is impaired as a result of such stresses as inhibition of rDNA transcription, serum deprivation and insufficiency of a protein component for ribosomal subunit assembly. 14, 16 Many ribosomal proteins possess an ability to bind and inhibit Mdm2 including RPL5, RPL11, RPL23, RPL26, RPS7, RPS27, RPS27a, RPS14 and RPS25. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] When cells are experiencing ribosomal stress, a fraction of these ribosomal proteins are released from the nucleoli and move into the nucleoplasm, where they bind and inhibit Mdm2, resulting in p53 stabilization and activation. Despite a growing list of ribosomal proteins that can bind to Mdm2, in many cases the ribosomal stress-induced p53 upregulation and activation depends on the presence of RPL5 and/or RPL11. [30] [31] [32] Therefore, the role of other ribosomal proteins in p53 activation is not clear, with the exception of L26 that also binds to the mRNA of p53 and enhances its translation. [33] [34] [35] Interestingly, many of the above mentioned ribosomal proteins such as RPL5, RPL11, RPS7 and RPL26 are mutated in human diseases such as Diamond-Blackfan Anemia (DBA), an inherited congenital bone marrow-failure syndrome characterized by anemia and associated with an increased risk of cancer. [36] [37] [38] The molecular mechanism for this cancer association is not known, but the close relationship of these ribosomal proteins with the p53 system suggests a role of these disease-related ribosomal proteins in p53 regulation.
RPS26 is a recently identified DBA-associated ribosomal protein. 39 We postulated that it may also regulate p53 activation. To test this hypothesis, we examined the effect of RPS26 knockdown and overexpression on p53, and revealed that in both situations p53 is upregulated but through different mechanisms. Knockdown of RPS26 generates ribosomal stress that induces p53 stabilization and 1 upregulation via RPL11, whereas overexpressed RPS26 stabilizes p53 by interacting with the acidic domain of Mdm2 and inhibiting its E3 ligase activity. More importantly, we found that RPS26 participated in the regulation of the transactivation activity of p53 by affecting p53 acetylation and recruitment to the promoters of its target genes, particularly in the scenario of DNA damage response. These findings support the notion that DBA-related ribosomal proteins are important factors in p53 activation and reveal regulation of p53 transactivation activity as a novel mechanism for their actions. Figure 1a) . 32, 40 Of note, knockdown of RPL11 in U2OS cells seemed to reduce p53 expression through an unknown mechanism. 25, 41 The upregulated p53 protein following RPS26 knockdown is relatively stable with an increased half-life ( Figure 1c) , and is transcriptionally competent, as both the protein and mRNA levels of the p53 target genes, Mdm2 and p21, were upregulated (Figures 1a and d) . To confirm that the observed increase in the expression of p53 target genes is indeed induced by p53, we simultaneously knocked down p53 and RPS26. As a result, the RPS26 knockdown induced an increase in the mRNAs of Mdm2, and p21 dramatically decreased (Figure 1d ). Furthermore, RPS26 knockdown-induced decrease in cell growth was also abolished when both RPS26 and p53 were knocked down by siRNAs (Figure 2c ). Altogether, our data suggest that knockdown of RPS26 stabilizes and activates p53, resulting in inhibition of cell growth and proliferation.
RESULTS

Knockdown
L11 is required for RPS26 depletion-induced p53 activation p53 upregulation is observed in many scenarios of ribosomal stresses including depletion of small subunit ribosomal protein such as S6, and is mainly mediated by RPL11 and/or RPL5 that binds and inhibits Mdm2. 30, 32, 42, 43 We therefore examined whether RPS26 knockdown-induced increase in p53 is also through such a mechanism. As expected, when both RPL11 and RPS26 were knocked down by their respective siRNA, the p53 level was not elevated compared with the control (Figure 2a) , and the cell growth retardation induced by RPS26 knockdown was also diminished (Figure 2c and Supplementary Figure S1 ). Thus, RPS26 depletion-induced p53 upregulation and cell growth reduction indeed required RPL11. Moreover, co-immunoprecipitation analysis indicated that the interaction between RPL11 and Mdm2 was enhanced upon RPS26 knockdown (Figure 2b ). Therefore, it is highly possible that RPS26 reduction causes ribosomal stress that results in an enhanced interaction between RPL11 and Mdm2, whereby Mdm2 is inhibited and p53 is stabilized.
Overexpression of RPS26 stabilizes p53
We next examined the effect of overexpression of RPS26 on p53. Plasmids encoding Flag-tagged RPS26 and RPL11 were individually transfected into HCT116 cells, followed by western blot analysis. When overexpressed, both RPL11 and RPS26 induced upregulation of endogenous p53 and its target genes, Mdm2 and p21 (Figure 3a) . It has been reported that overexpression of RPL11 stabilizes p53 by inhibiting Mdm2-mediated p53 ubiquitination and degradation. 19, 20 We also observed that p53 has a prolonged half-life in RPS26-overexpressed cells compared with that of control cells, suggesting that p53 is stabilized by RPS26 (Figure 3b ). Similarly to RPL11, RPS26 has the ability to inhibit Mdm2-induced p53 destruction (Figure 3c ). Accordingly, Mdm2-induced p53 ubiquitination was diminished when either RPL11 or RPS26 was present (Figure 3d ). Therefore, on condition of overexpression, both RPL11 and RPS26 were able to stabilize p53 by inhibiting Mdm2-mediated p53 ubiquitination and degradation.
RPS26 interacts with Mdm2 and inhibits its auto-ubiquitination activity The mechanism for RPL11 inhibiting the E3 ligase activity of Mdm2 to p53 is attributed to its interaction with the acidic region of Mdm2. 14, 19, 20 We therefore examined whether RPS26 interacts with Mdm2. In an overexpression condition, RPS26 readily pulled down Mdm2 in a co-immunoprecipitation assay and vice versa (Figure 4a ). This interaction was also confirmed at endogenous protein levels (Figure 4b ). Further mapping analysis showed that the region of Mdm2 amino acids 200-299 that encompasses the acid-rich domain mediated the interaction with RPS26 (Figure 4c ). To determine whether RPS26 directly affects Mdm2 without the involvement of p53, we transfected RPS26 into a p53-deficient cell line H1299. Western analysis indicated that RPS26 overexpression notably augmented the endogenous levels of Mdm2 in a dosagedependent manner, suggesting that RPS26 directly stabilizes Mdm2 (Figure 4e ). Accordingly, RPS26 strongly inhibited the autoubiquitination activity of Mdm2 (Figure 4f ). Intriguingly, we found only low doses of RPL11 inhibited Mdm2 auto-ubiquitination, whereas high doses of RPL11 slightly enhanced Mdm2 autoubiquitination (data not shown), suggesting that L11 may inhibit the E3 activity of Mdm2 at low doses, whereas excess amount of L11 may block 26S proteasome-mediated degradation of ubiquitinated Mdm2 as proposed by Dai et al.
44
RPS26 regulates p53 transcriptional activity in response to DNA damage Next, we investigated whether RPS26 has any role in stressinduced p53 activation. We first examined whether RPS26 participated in ribosomal stress-induced p53 activation. IMR90 or HCT116 cells were transfected with individual siRNA and then treated with low dose of Actinomycin D (ActD) or fluorouracil (5-FU). Consistent with previous reports, knockdown of RPL11 nearly abolished ActD or 5-FU-induced upregulation of p53 as well as its target genes Mdm2 and p21 (Supplementary Figure S3B and data not shown). 14, 25, 41, 45 In contrast, knockdown of RPS26 showed minimal effects on p53 protein level and stability ( Figures  5a-d) , and only slightly reduced upregulation of p21 and Mdm2 in HCT116 cells (Figure 5b ). These results suggest that in the setting of ribosomal stress, the effect of RPS26 on p53 is likely overshadowed by RPL11 but hint that RPS26 may have some role in p53 transactivation.
We subsequently assessed the effect of knockdown of RPS26 on DNA damage-induced p53 activation. We treated siRNAs transfected cells with Doxorubicin (Dox), and then collected the cells at different time points for western analysis and real-time PCR measurement. As shown in Figures 6a and c, RPS26 knockdown did not affect p53 induction by Dox, but significantly impaired upregulation of p21 and Mdm2 at both protein and mRNA levels, especially at later time points of treatment. This impairment is more evident in HCT116 cells (Figure 6b ). Half-life measurement indicated that at 12 h of Dox treatment, p53 has a similar half-life in both control siRNA and RPS26 siRNA-treated cells (Figure 6d ). Thus, these observations suggest RPS26 is not involved in DNA damage-induced p53 stabilization, but participated in the regulation of p53 transactivation activity. To examine whether knockdown of RPS26 affects the cellular response to DNA damage, RPS26 regulates p53 activity in response to DNA damage D Cui et al we performed cell cycle analysis and found that RPS26 knockdown undermined Dox-induced cell cycle arrest at G2/M, underscoring the importance of RPS26 in DNA damage response ( Figure 6e ).
RPS26 reduction impairs DNA damage-induced p53 acetylation and recruitment to the promoters of its target genes To address the mechanisms by which RPS26 regulates p53 transactivation activity induced by DNA damage, we turned to p53 modifications, as modification is another important mechanism for p53 activation in addition to stabilization. 46 Serine 15 of p53 is a key residue, being phosphorylated by the ATM/ATR kinase cascade in response to DNA damage. 47, 48 We therefore examined its phosphorylation. Not surprisingly, the robust increase in pS15 of p53 on DNA damage is not markedly altered in RPS26 siRNA-transfected IMR90 and HCT116 cells (Figures 7a  and b) . These results are consistent with the finding that knockdown of RPS26 did not affect DNA damage-induced p53 stabilization, as S15 phosphorylation is critical for this process. In line with the reported role of acetylation in regulating transactivation activity, 11, 12 we found that acetylation of Lysine 382 of p53, a prominent acetylation event, was significantly decreased in both cell lines examined upon RPS26 knockdown, suggesting that RPS26 is involved in the regulation of p53 acetylation (Figures 7a and b). Knockdown of RPS26 using another siRNA against RPS26 also resulted in defects in p53 acetylation and upregulation of p53 target genes in response to DNA damage (Supplementary Figure S4) . Additionally, we examined the ability of p53 binding to the promoters of its target genes upon RPS26 knockdown by performing a chromatin immunoprecipitation (ChIP) assay. In control siRNA-transfected cells, basal p53 was found to bind to the promoters under unstressed conditions and substantial amounts of p53 were recruited to these promoters after DNA damage (Figure 7c ). In contrast, in RPS26 siRNA-transfected cells, a significant amount of p53 was bound to the promoters in unstressed cells consistent with activation of p53 upon RPS26 knockdown. However, strikingly DNA damage treatment failed to further recruit p53 to the promoters (Figure 7c ). Together, these results suggest that in RPS26-depleted cells, DNA damage can still induce p53 accumulation, but the upregulated p53 failed to be acetylated and were unable to bind to the promoters of its target genes.
RPS26 binds to p53 independent of Mdm2, and coexists in a complex with p53 and p300 To investigate the mechanism by which RPS26 regulates p53 acetylation, we examined the interaction between RPS26 and p53, and found RPS26 interacting with p53 and this interaction was enhanced upon Dox treatment (Figure 8a ). To rule out the role of Mdm2 in mediating this interaction, we examined the RPS26-p53 interaction in mouse embryonic fibroblast cells deficient in both p53 and Mdm2 (p53 À / À Mdm2 À / À mouse embryonic fibroblast), and demonstrated that RPS26 can interact with p53 in the absence Mdm2 (Figure 8b ). Next, we examined if RPS26 had a role in p53 acetylation by p300, as p300 is a prominent acetyltransferase for p53. 11 Our results indicated that RPS26, p53 and p300 possibly existed in the same complex, as when these three proteins were coexpressed in H1299 cells, both RPS26 and p53 were detected in the p300-immunoprecipitated complex (Figure 8c ). In addition, we found DNA damage induced the translocation of RPS26 from the nucleoli to small bodies, and in some of these bodies RPS26 colocalized with p53 or p300 (Supplementary Figures S5A-C) . Altogether, these results suggest that RPS26 may facilitate p53 acetylation by p300.
DISCUSSION
Many ribosomal proteins possess extraribosomal functions. With respect to RPS26, its extraribosomal functions have rarely been characterized. Only a few reports showed that RPS26 binds and suppresses the splicing of its pre-mRNA. 49 Recently, RPS26 mutations have been found in DBA patients, suggesting that it is functionally important. 39 In this study, we revealed RPS26 as a novel regulator of p53. We showed that both RPS26 depletion and overexpression induced p53 activation, but through different mechanisms. Moreover, we found that RPS26 had an important role in DNA damage response by modulating p53 acetylation and transactivation. Considering most ribosomal proteins regulate p53 activity by inhibiting Mdm2, our results indicate that p53 transcriptional control is another important regulatory mechanism of ribosomal proteins.
Our results support the previous reports that assembly of either small or large subunits of a ribosome is monitored by an RPL5-and/or RPL11-mediated p53 surveillance system. 30, 32 Knockdown of RPS26-induced p53 elevation and cell growth inhibition was abrogated upon co-knockdown of RPL11. Intriguingly, we found that this p53-dependent surveillance system detecting the lack of RPS26 or maybe other ribosomal proteins is much more sensitive in unstressed normal cells (IMR90 cells with passage numbers , 6b and 7b) . In HCT116 cells, only when RPS26 was sufficiently knocked down, can p53 upregulation and activation be observed (data not shown). Cancer cells that have experienced various stresses after long-term culture may have adopted strategies to comprise the sensitivity of this system. We found that knockdown of RPS26 does not have a noticeable effect on nucleolar integrity (Supplementary Figure S2) , but enhances the interaction between RPL11 and Mdm2 (Figure 2b) . Knockdown of RPS6, RPL7 and RPL23 also has no effect on nucleolar integrity, but elicit p53 induction. 32, 40 Two possible mechanisms could explain this enhanced interaction. One is that disruption of small subunits of ribosomes leads to an enhanced translation of RPL11 through a 5 0 -top-mediated mechanism. 32 The other is that disruption of ribosomal subunit enhances the neddylation and nuclear retention of RPL11, thus increasing its interaction with Mdm2. 50 Ribosomal stress also induces Mdm2 neddylation. 51 As we did not observe the upregulation of RPL11 upon RPS26 knockdown, the enhanced interaction is likely due to neddylation of either or both proteins.
As reported with regards to many ribosomal proteins interacting with Mdm2, RPS26 also possesses the ability to bind with Mdm2, allowing it to inhibit the E3 activity of Mdm2, leading to p53 stabilization. Thus, the protein levels of these ribosomal proteins require delicate control, as otherwise p53 induction is evoked. Indeed, free nucleoplasmic ribosomal proteins are subject to rapid degradation. 14, 52 In this regard, it is tempting to speculate that degradation of ribosomal proteins, especially these Mdm2-interacting ribosomal proteins, are very important for normal cell growth. However, this line of research is currently lacking.
It has been established that RPL5 and RPL11 are prominent p53 inducers in response to ribosomal stress, which raises the question of the roles of other ribosomal proteins released into the nucleoplasm. 40, 42 In this study, we made an important discovery that RPS26 is required for p53 transcriptional activity especially in response to DNA damage, and suggests that ribosomal proteins may directly influence p53. In RPS26-depleted cells, despite being normally induced by DNA damage treatment, p53 failed to efficiently transactivate its target genes. This is likely due to the impaired ability of p53 to bind to the promoters of target genes in addition to defects in p53 acetylation. Regulation of the transcriptional activity of a transcription factor by a ribosomal protein has been reported for several other ribosomal proteins. RPS26 regulates p53 activity in response to DNA damage D Cui et al RPS3 has been found to form a complex with NF-kappa B and controls transcription of selected p65 target genes.
53 RPL11 inhibits c-myc but stimulates p53 transcriptional activity. 19, 54 RPL23 negatively regulates Miz1-dependent transactivation. 55 In addition, we found RPS26 also regulated p53 transcriptional activity in response to ribosomal stress in HCT116 cells, but with a less dramatic effect (Figure 5b ). Low doses of ActD disrupt nucleoli, resulting in the release of many nucleolar residential proteins into the nucleoplasm. In this setting, the effect of RPS26 on p53 activity is likely masked by other ribosomal proteins with redundant functions. The same is probably true for the effect of RPS26 on Mdm2.
Stress-induced p53 activation requires not only p53 stabilization but also modifications, especially acetylation, which also enhance p53 binding to its specific promoters. 11, 12 Recently, it was shown that the nucleolar protein MYBBP1A promotes p53 acetylation by enhancing the interaction between p53 and p300 in response to ribosomal stress. 56 Very recently, it was reported that RPL11 is required for p53 acetylation and p300 recruitment to the promoter regions of p53 target genes in response to ribosomal stress. 57 Our results suggest that RPS26 is able to reside in the same complex as p53 and p300, possibly through its interaction with p53 in response to DNA damage, whereby promoting p53 acetylation by p300. The observation that knockdown of RPS26 did not affect ActD-induced p53 acetylation again indicates that other nucleolar proteins (Supplementary Figure S3A) , as above mentioned MYBBP1A, have more prominent role in p53 activation in response to ribosomal stress. Despite being involved in different pathways, all these data indicate that nucleolar proteins are important factors in regulating p53 acetylation and transaction activity. RPS26 regulates p53 activity in response to DNA damage D Cui et al p53 regulation by ribosomal proteins is not limited to ribosomal stress, but has extended to DNA damage. It has been clearly demonstrated that RPL26 enhances p53 translation in response to DNA damage. 33 Upon knockdown of RPS7, DNA damage-induced upregulation of p53 target genes was reduced, although no mechanistic insights were provided. 25 Our data unequivocally demonstrated that RPS26 is required for DNA damage-induced p53 transactivation and cell cycle arrest. The nucleolus has been proposed as a stress sensor, as its integrity is affected to different degrees in response to a variety of stress stimuli. 15, 58 RPL37 has been shown to be degraded upon the introduction of DNA damage, which in turn triggers ribosomal stress. 31 We propose that nucleoli could regulate the DNA damage response by shedding some specific nucleolar proteins, including RPS26, to modulate p53 activity and other cellular responses. Indeed, the localization of RPS26 is changed following DNA damage, suggesting that the nucleoli sensed the stress triggered by DNA damage and responded accordingly (Supplementary Figure S5A) . In short, we provided evidence to suggest RPS26 critically regulates p53 activity in response to DNA damage.
MATERIALS AND METHODS
Cell culture and plasmids
Human IMR90, HCT116, H1299 and p53 À / À Mdm2 À / À mouse embryonic fibroblast cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 U/ ml streptomycin at 37 1C in a humidified incubator supplied with 5% CO 2 . Plasmids expressing Flag-p53, Flag-Mdm2, Ha-Mdm2, Mdm2-pCMV and HA-ubiquitin were described previously. 59 Plasmids expressing N-terminal Flag-or Myc-tagged RPS26 and RPL11 were generated by PCR and cloned into pRK5 or pCMV vector, respectively. All deletion mutants were generated by PCR. The PCR primers for constructs: Flag-RPS26 forward: 
Antibodies and drugs
The following antibodies were used for immunoprecipitation and western blotting: p53 (DO-1, FL-393), HA (Y-11), Actin (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) and Myc (9E10), all from Santa Cruz Biotechnology (Santa Cruz, CA, USA); acetylated p53 (Lys382) and phosoho-p53 (Ser15) both from Cell Signaling Technology (Danvers, MA, USA); Human Mdm2 (Ab-1) from Calbiochem (San Diego, CA, USA); p21 from BD Biosciences (San Jose, CA, USA); RPS26 and RPL11 both from ProteinTech (Wuhan, China); Flag (M2) from Sigma-Aldrich (St Louis, MO, USA). The following drugs were used in this study: Dox from Sigma-Aldrich; ActD and cycloheximide from Amresco (Solon, OH, USA); MG132 from Beyotime Institute of Biotechnology (Haimen, China).
RNA interference and transfection
The siRNA target sequences for endogenous RPS26 (S26-1 and S26-2), RPL11 and p53 were described previously. 32, 39, 60 The non-silencing RPS26 regulates p53 activity in response to DNA damage D Cui et al
Immunofluorescence microscopy
The cells cultured on coverslips were transfected with siRNAs. At 24 h post transfection, cells were sequentially fixed with 4% paraformaldehyde for 15 min, permeabilized with 0.2% Triton X-100 for 15 min, blocked with 1% bovine serum albumin and incubated with an anti-p53 (FL-393) antibody, followed by a FITC-conjugated anti-rabbit IgG antibody. The cells were mounted with 4 0 ,6-diamidino-2-phenylindole-containing medium (Beyotime Institute of Biotechnology) and the images were acquired with a fluorescence microscope.
Immunoprecipitation and western blotting
Immunoprecipitation of endogenous proteins were performed as described previously. 59 In brief, cells were lysed in lysis buffer (50 mM Tris-Cl at pH 8.0, 150 mM NaCl, 1% Triton X-100, 1 mM DTT, 1 Â complete protease inhibitor cocktail and 10% glycerol) and pre-cleared with protein G Sepharose beads (GE Healthcare, Piscataway, NJ, USA) for 2 h at 4 1C. The lysates were then immunoprecipitated with indicated antibodies or isotype-matched control antibodies plus protein G Sepharose for overnight. Beads were washed and boiled. Protein samples were analyzed by western blot. For immunoprecipitation of overexpressed Flag-tagged proteins, cell lysates were incubated with M2 beads for 2-4 h at 4 1C before western blot analysis.
For western blotting, cells were either directly lysed in 2 Â sodium dodecylsulphate (SDS) sample buffer or extracted as described above and then added to SDS sample buffer. The prepared protein samples were resolved by SDS-PAGE and transferred onto a polyvinylidene difluoride membrane, which was blocked in 5% skim milk in PBST and probed with the indicated antibodies.
In vivo ubiquitination assay
In vivo ubiquitination assays were conducted as described previously. 59 In brief, HCT116 or H1299 cells were transfected with the indicated plasmids. At 20 h post transfection, the cells were treated with MG132 for 4 h and then lysed in 1% SDS. After boiling for 10 min, lysates were diluted 10 times with cold lysis buffer supplemented with 1 Â complete protease inhibitor cocktail and 10 mM N-ethylmaleimide (Sigma-Aldrich). Flag-p53 (Figure 3d After two washes with cold phosphate-buffered saline, ChIP was performed using ChIP Assay Kit (Millipore, Billerica, MA, USA) according to the manufacturer's protocol. Anti-p53 (FL-393) was used for immunoprecipitation. After reverse crosslinking, the DNA samples were recovered by phenol extraction and ethanol precipitation. The purified DNA was then analyzed by PCR within linear amplification range followed by 2% agarose gel electrophoresis. The primer sequences were as follows: p21 forward Cell growth assay
MTT assay was used to measure cell growth. IMR90 cells transfected with the indicated siRNAs were seeded at 2 Â 10 3 cells per well and grown in 96-well plates for 48 h. The 20 ml MTT (1 mg/ml) was added and incubated for 4 h at 37 1C, followed by aspiration of the medium and addition of 200 ml of dimethyl sulfoxide. Absorbance was measured at a wavelength of 490 nm using a microplate reader (Thermo Scientific Multiskan GO, Thermo Fisher Scientific, Waltham, MA, USA).
Cell cycle analysis IMR90 cells transfected with siRNAs were treated with 0.4 mg/ml Dox for 16 h. Cells were then harvested, fixed with 70% cold ethanol and stained with propidium iodide (PI; Sigma-Aldrich) staining solution (50 mg/ml of PI, 100 mg/ml of RNaseA and 0.1% Triton X-100 in phosphate-buffered saline, pH 7.4) at room temperature for 15 min. DNA content was analyzed by flow cytometry, using a FACS Calibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). RPS26 regulates p53 activity in response to DNA damage D Cui et al
